Vanguard Global Advisers »

Evommune shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $86k 3.8k 22.99

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Evommune

EQT Fund Management S.a r.l.
RA Capital Management
Pivotal bioVenture Partners Investment Advisor
Andera Partners
MPM Oncology Impact Management
Nan Fung Group Holdings
Rtw Investments
SymBiosis Capital Partners
Marshall Wace
Eventide Asset Management
Henderson Group
Baker Bros. Advisors
Alyeska Investment Group
BlackRock
Kynam Capital Management

View all funds holding Evommune